BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37458005)

  • 21. Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer.
    Xu L; Xu W; Qiu S; Xiong S
    Clin Immunol; 2010 Jun; 135(3):466-75. PubMed ID: 20181533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumoral FOXP3 has potential oncogenic function in conjunction with the p53 tumor suppressor protein and infiltrated Tregs in human breast carcinomas.
    Won KY; Kim HS; Sung JY; Kim GY; Lee J; Park YK; Kim YW; Suh JH; Lim SJ
    Pathol Res Pract; 2013 Dec; 209(12):767-73. PubMed ID: 24071443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer.
    Shen Z; Zhou S; Wang Y; Li RL; Zhong C; Liang C; Sun Y
    J Cancer Res Clin Oncol; 2010 Oct; 136(10):1585-95. PubMed ID: 20221835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast.
    Xu Y; Lan S; Zheng Q
    Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients.
    Maeda N; Yoshimura K; Yamamoto S; Kuramasu A; Inoue M; Suzuki N; Watanabe Y; Maeda Y; Kamei R; Tsunedomi R; Shindo Y; Inui M; Tamada K; Yoshino S; Hazama S; Oka M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(Suppl 4):S546-54. PubMed ID: 24562936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
    Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
    Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
    Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
    Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of immunoregulatory T cells in different stages of breast cancer patients.
    Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E
    Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CD8 and FOXP3 expression in stromal tumor-infiltrating lymphocytes of triple-negative breast carcinomas: a clinicopathologic study].
    Pan BJ; Ping GQ; Zhang WM; Wang C; Li HX; Zhang ZH
    Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):540-4. PubMed ID: 27510779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.
    Ghebeh H; Barhoush E; Tulbah A; Elkum N; Al-Tweigeri T; Dermime S
    BMC Cancer; 2008 Feb; 8():57. PubMed ID: 18294387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.
    West NR; Kost SE; Martin SD; Milne K; Deleeuw RJ; Nelson BH; Watson PH
    Br J Cancer; 2013 Jan; 108(1):155-62. PubMed ID: 23169287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the role CD163-labeled TAMs and FOXP3-labeled Tregs in different types of breast cancer: Reflections and putative benefits.
    Shash LS; M Kamal KA; Abd Raboh NM
    Indian J Pathol Microbiol; 2021; 64(1):28-37. PubMed ID: 33433406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.
    Preston CC; Maurer MJ; Oberg AL; Visscher DW; Kalli KR; Hartmann LC; Goode EL; Knutson KL
    PLoS One; 2013; 8(11):e80063. PubMed ID: 24244610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
    Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
    Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer.
    Sarkar T; Dhar S; Chakraborty D; Pati S; Bose S; Panda AK; Basak U; Chakraborty S; Mukherjee S; Guin A; Jana K; Sarkar DK; Sa G
    Front Immunol; 2022; 13():740588. PubMed ID: 35222362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
    Zhu S; Lin J; Qiao G; Xu Y; Zou H
    Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer.
    Ishigami E; Sakakibara M; Sakakibara J; Masuda T; Fujimoto H; Hayama S; Nagashima T; Sangai T; Nakagawa A; Nakatani Y; Otsuka M
    Breast Cancer; 2019 Mar; 26(2):180-189. PubMed ID: 30244409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
    Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
    J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ICOS
    Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
    Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.